Pattern of Metastasis in Cervical Lymph Nodes and Topographic Distribution of Primary Site: Study of 375 Case

Jetly D.1, Thummar S.

1Dr. Dhaval Jetly, Associate Professor and Head, 2Dr. Siddharth Thummar, Resident Doctor; Both Authors are Attached with Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, India.

Corresponding Author: Dr. Siddharth Thummar, Resident Doctor, Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, India. E-mail: siddharthkpatel@yahoo.co.in


Abstract

Introduction: Lymph nodes are the most common site of metastatic malignancy and presence of metastatic tumor in lymph nodes is essential for the management and prognosis of cancer. Cervical lymph node metastasis most commonly develop from oral cavity malignancies. Tumors of Upper Aerodigestive tract, Salivary and Thyroid glands and any other sites of the body can present as cervical nodal metastasis. The topographic correlations are helpful clues to the most common sites of origin of metastases in cervical lymph nodes. Objectives: (1) Typing of Metastatic Tumor, its Prevalence and Demographic Incidence in cervical lymph nodes. (2) Distribution of Cervical lymph node metastasis & Relevance to probable Primary Site. Methodology: In the study, FNAC and/or Biopsy were taken from enlarged cervical lymph nodes to confirm the metastatic tumor and to type the tumor. IHC was done whenever necessary for diagnosis and to confirm the primary site. Relevant clinical details and patient history were collected from patients’ case file and electronic patients’ records. Total 375 malignant metastatic cases were included in the study for analysis. Conclusion: SCC from head and neck region is the most common metastatic malignancy present in the cervical lymph nodes. SCC from Lung, Esophagus or Cervix can also present as metastatic lymph node. Adenocarcinoma and Neuroendocrine carcinoma from Lung or GI Tract in Males & Ductal Carcinoma of Breast and Papillary Thyroid Carcinoma in Females can also involve Neck Lymph nodes.

Key words: Cervical Lymph node, Metastasis, Primary site, SCC


Manuscript received: 10th February 2019 Reviewed: 20th February 2019 

Author Corrected: 28th February 2019 Accepted for Publication: 5th March 2019

Introduction

Lymph nodes are the most common site of metastatic malignancy and sometimes constitute the first clinical manifestation of the disease. The task of the pathologist is to identify the presence of a malignant process in the node, to establish whether it is metastatic or not, andif, metastaticto provide an estimate of its amount, microscopic type, and possible source. Establishing the presence of metastatic tumor in lymph nodes is essential for the management and prognosis of cancer. In solid tumors, lymph node status is the most important indicator of clinical outcome [1].

Cervical lymph node metastasis most commonly but, not always develop from oral cavity malignancies. Apart from oral malignancies, squamous cell carcinoma of the upper Aerodigestive tract, Salivary gland malignancies, Thyroid cancers and skin cancers of head and neck region can present as cervical nodal metastasis. Cervical lymph nodes, particularly upper jugular and posterior cervical nodes, drain the head and neck and may harbour metastatic carcinomas originating in the Nasopharynx, Tonsillar fossa, Tongue, Floor of the mouth, Thyroid, Extrinsic larynx, Facial skin, and Scalp. Scalene lymph nodes representing the lower, deep jugular chain are commonly the site of metastases from Intrathoracic carcinomas, particularly in the Lungs. The supraclavicular lymph nodes are most often the site of metastases of Intra abdominal cancers. The left supraclavicular lymph node, frequently invaded by Gastric carcinoma and less commonly other Gastro intestinal tract carcinoma, is classically known as the Virchow node. The topographic correlations are helpful clues to the most common sites of origin of metastases in various groups of regional lymph nodes [2].Besides all this, Infraclavicular malignancies can also present as neck node metastasis.

Not infrequently, a lymph node metastasis is discovered before an occult primary tumor is detected. In such cases, to identify the Unknown primary tumor, extensive studies of the lymph node metastases, including immunohistochemistry in addition to detailed histopathology, are often necessary. It is estimated that 5 to 7% of cancer patients present with a metastatic tumor of unknown origin [3,4].Carcinomas of the Nasopharynx and Oropharynx are notorious for presenting with metastases in the cervical lymph nodes while the primary neoplasm remains unnoticeable [5]. Sometimes tumors like base of tongue or hypopharynx with local spread may present as nodal mass in neck and finding of primary site is difficult clinically or radiologically. Not uncommonly, the histologic pattern and cell morphology characteristic of a tumor are no longer recognizable in its metastases. Identifying the primary tumor may be difficult, often frustrating, yet indispensable for treatment. All available methods of cytopathology, histopathology and immunohistochemistry along with thorough clinico-radiological evaluation are required for typing and subtyping of metastatic tumor.

Aims of This Study are

1)    Typing of Metastatic Tumor and its Prevalence in Cervical Lymph Nodes.

2)    Demographic Incidence of Metastatic Cervical Lymph Nodes.

3)    Distribution of Cervical Lymph Node Metastasis & Relevance to probable Primary Site.

Material and methods

Type of study: Prospective study

Sample Collection and Methods:The present study was conducted on patients present with cervical lymph node enlargement during the period of one year.In the study, FNAC and/or Biopsy were taken from enlarged cervical lymph nodes to confirm the metastatic tumor and to type the tumor. For the further typing of tumor, Immunohistochemistry was done whenever necessary.

Inclusion Criteria: All (n=375) malignant metastatic cases of cervical lymph nodes were included in the study. Patients with known and unknown primary tumor site were included.

Exclusion Criteria: Patients with primary neoplasm of lymph node e.g. malignant lymphoma and Post-surgery specimens of modified neck dissection in which lymph nodes are positive for metastatic tumor were excluded.

 

Analysis: Out of total 375 cases, FNAC was done on 137 cases and both FNAC and Biopsy were done on 36 cases. Rest of the cases were confirmed by Biopsy. IHC was performed in 70 cases out of total 375 cases which could not be classified on histopathology or primary sites of tumor was not known.

Relevant clinical details and patient history were collected from patients’ case file and electronic patients’ records. To determine primary site in cases of unknown primary, radiological details were noted and Immunohistochemistry (IHC) was performed on tissue blocks. All cytological, histological and/or Immunohistochemical findings were noted and reviewed for morphological diagnosis.

Statistical Methods: Statistical analysis was performed on collected data using standard statistical software (SPSS).

Ethical Considerations: No Ethical Issue related to the study.

Result

In the Present Study, A Total of 375 consecutive Cases having Metastatic Cervical Lymphadenopathy were Included for Analysis.

Table-1: Demographic distribution of Metastatic Cervical Lymphadenopathy

Age Group

Frequency

Percentage

0-20

8

2.13%

21-40

41

10.93%

41-60

200

53.33%

61-80

121

32.27%

81-100

5

1.33%

Total

375

100.00%

Sex

Males- 298 (79.47%)

Females- 77 (20.53%)

Table-2: Metastatic Pattern in Malignant Cervical Lymph Nodes

Metastatic tumor

Frequency

Percentage

Adenocarcinoma

28

7.47%

Anaplastic carcinoma thyroid

2

0.53%

Ductal carcinoma breast

24

6.40%

Germ cell tumor

2

0.53%

Granulocytic sarcoma

3

0.80%

Nasopharyngeal carcinoma

4

1.06%

Neuroendocrine carcinoma

20

5.33%

Papillary thyroid carcinoma

9

2.40%

Poorly diffentiated carcinoma

11

2.93%

Squamous cell carcinoma

262

69.87%

Others*

10

2.66%

Total

375

100.00%

*Others include Epithelioid Sarcoma, High grade Serous Carcinoma Ovary, Medullary Carcinoma Thyroid, Medulloblastoma, Malignant Melanoma, PNET, RCC, Sarcomatoid Carcinoma, Spindle cell Sarcoma

Table-3: Distribution of Metastatic Tumors in Females

Metastatic tumor

Frequency

Percentage

Adenocarcinoma

5

6.49%

Anaplastic carcinoma thyroid

2

2.60%

Ductal carcinoma breast

24

31.17%

Granulocytic sarcoma

2

2.60%

Neuroendocrine carcinoma

2

2.60%

Papillary thyroid carcinoma

7

9.09%

Squamous cell carcinoma

31

40.26%

Others*

4

5.19%

Total

77

100.00%

*Others include High grade Serous Carcinoma Ovary, PDCA, PNET, Nasopharyngeal Undifferentiated Carcinoma

Table-4: Distribution of Metastatic Tumors in Males

Metastatic tumor

Frequency

Percentage

Adenocarcinoma

23

7.72%

Germ cell tumor

2

0.67%

Nasopharyngeal carcinoma

3

1.00%

Neuroendocrine carcinoma

18

6.04%

Papillary thyroid carcinoma

2

0.67%

Poorly differntiated carcinoma

10

3.36%

Squamous cell carcinoma

231

77.52%

Others*

9

3.02%

Total

298

100.00%

*others include epithelioid sarcoma, granulocytic sarcoma, medullary carcinoma thyroid, medulloblastoma, malignant melanoma, PNET, RCC, sarcomatoid carcinoma, spindle cell sarcoma

Table-5: Distribution of Primary Site in Metastatic SCC

Primary site

Frequency

percentage

Alveolus

3

1.15%

Angle of mouth/lip

2

0.76%

Buccal mucosa

37

14.12%

Base of tongue

34

12.98%

Cervix

4

1.53%

Esophagus

10

3.82%

Eyelid

1

0.38%

Larynx

54

20.61%

Lung

14

5.34%

Maxilla

4

1.53%

Nasopharynx

8

3.05%

Oropharynx

7

2.67%

Palate

5

1.91%

Scalp ulcer

1

0.38%

Tongue

19

7.25%

Tonsil

14

5.34%

Unknown

23

8.78%

Vallecula

22

8.40%

Total

262

100.00%

Table-6: Distribution of Primary Site in Metastatic Adenocarcinoma

Primary site

Frequency

Percentage

Esophagus

4

14.29%

Gall bladder

1

3.57%

Lung

15

53.57%

Ovary

3

10.71%

Rectum

2

7.14%

Stomach

3

10.71%

Total

28

100.00%

Table-7: Distribution of Primary Site in Metastatic Neuroendocrine Carcinoma

Primary site

Frequency

Percentage

Esophagus

1

5.00%

Lung

16

80.00%

Mediastinal mass

1

5.00%

Pancreas

1

5.00%

Thymus

1

5.00%

Total

20

100.00%

Discussion

In the present study, we analysed 375 cases of metastatic cervical lymph nodes confirmed by FNAC and/or Biopsy.

Majority of the cases were of age group 41-60 years i.e. 53% cases followed by age group 61-80 years i.e. 32% cases(Table-1). Age ranges were almost comparable to the study done by Naresh et al[6], in which most common age group was also 41-60 years i.e. 54% followed by 61-80 years i.e. 25%.

Males were most frequently involved in present study i.e. 80%.(Table-1) Most common secondary malignancy found in cervical lymph node was squamous cell carcinoma i.e. 70% of total metastatic tumors (Table-2) But in males, the percentage was higher i.e. 78% and in females, it was only 40%. After squamous cell carcinoma, most common malignant metastatic tumor found was adenocarcinoma of lung i.e. 7% in males. In females, most common malignant metastatic tumor found in cervical lymph nodes after squamous cell carcinoma was ductal carcinoma breast i.e. 31% followed by papillary carcinoma of thyroid i.e. 10% (Table 3,4)

Out of total 70% cases of metastatic SCC, most common primary site was oral cavity i.e. 25%, followed by pharynx i.e. 24% and larynx i.e. 21% cases. Lung and esophagus squamous cell carcinoma are not uncommon. Rare primary sites were eyelid, scalp, maxilla and cervix. (Table-5) In study by Candela et al[7], metastases were frequent in oral cavity tumors, with a mean prevalence of 30.1 %. The corresponding figure for oropharyngeal cancer was 10.3 %, largelybecause of the high prevalence in N + disease [7].

Out of total 8% cases of metastatic adenocarcinoma i.e. 28 cases, most common primary site found was lung in 54% cases followed by esophagus and ovary i.e. 15% and 11% respectively. (Table-6) A study of 58 cases of remote metastasis in cervical lymph nodes done by Wagh A[8]also found 41% cases of lung metastasis in supraclavicular lymph nodes that is comparable to present study. Davis et al [9] reported the frequency of cervical lymph node involvement in patients with lung cancer, to vary from 1.5% to 32%.

Out of total 5.3% cases of neuroendocrine carcinoma i.e. 20 cases, most common primary site found was lung in 80% cases. Other rare sites were esophagus, mediastinal mass, thymus and pancreas i.e. 1 case each (Table-7) Metastatic ductal carcinoma of breast was found in total 6.4% of cases and in females, it was present in nearly 30% of cases. Although the occurrence of neck metastases in breast carcinoma is low (2.3% to 4.3%)[10-13], breast cancer is the most common distant primary to metastasize to neck lymph nodes.12The cervical nodes most often affected are the supraclavicular lymph nodes; jugular chain metastases are an extraordinarily rare event (≤0.5% of cases) [14].

Metastatic papillary carcinoma of thyroid was found in total 2.4% of cases and in females, it was present in 9% cases. (Table-2,3)El-Foll HA[15] has done study of 44 cases diagnosed with papillary carcinoma of thyroid and found nearly 40% cases with neck lymph node metastasis. In view of this and present study, papillary carcinoma and other malignancy of thyroid are to be considered in differential diagnosis in metastatic cervical lymph nodes especially in females.

In any malignancy, presence or absence of lymph node metastasis is the most significant prognostic factor in view of management and survival [1]. Cervical lymph nodes are group of nearly 300 smalls to medium sized lymph nodes present on either side of neck [16]. They are classified into numeric levels i.e. level I to VI according to anatomic location of lymph nodes [17]. Cervical lymph nodes drain the head and neck region and harbour metastasis from regional head and neck SCC i.e. from oral cavity, pharynx, larynx or facial skin. Left supraclavicular or Virchow’s lymph nodes are connected to the thoracic duct and are involved in various tumors located distant to the neck region or tumors located infraclavicular compartment [17].

Wide range of the pattern of metastasis to the neck lymph nodes are present. Tumors with known primary sites of oral cavity and upper aero digestive tracts i.e. pharynx, larynx are the most common metastatic malignancies found in the neck lymph nodes [18]. Tumors with known primary site other than oral cavity or upper aero digestive tract i.e. breast, lung, gastrointestinal tract, thyroid, urogenital tract, central nervous system, various sarcomas or haematolymphoid malignancies are found not uncommonly in metastatic neck lymph nodes [2]. Patients with unknown primary site of tumors are also present commonly with cervical lymph node metastasis. Most frequent secondary malignancies in cervical lymph nodes in which primary sites remain unknown are squamous cell carcinoma metastasise from nasopharynx, oropharynx and hypopharynx [19]. In metastatic adenocarcinoma to cervical lymph nodes, most common primary site is to be the lung in males and breast ductal carcinoma in females [11]. Sometimes patients present with occult metastasis in cervical lymph nodes, in which primary site is not found even after vigorous search by means of imaging or blind biopsy techniques [20]. Other type of patients with cervical lymph node metastasis are that they present months or years after successful surgery, chemotherapy or radiotherapy i.e. recurrence/relapse after cure.

Conclusion

SCC is the most common metastatic malignancy present in the cervical lymph nodes. SCC spreads from regional Head and Neck primary sites most commonly but not always. SCC from Lung, Esophagus or Cervix can also present as metastatic lymph node in Head and Neck and should be considered as differential diagnosis when primary tumor site not known. In patients younger than 20 years of age, malignancy other than SCC should always keep in differential diagnosis like Nasopharyngeal Carcinoma or Haematolymphoid Malignancy. Not uncommonly, other secondary malignancies like Adenocarcinoma and Neuroendocrine carcinoma from Lung or GI Tract in Males & Ductal Carcinoma of Breast and Papillary Thyroid Carcinoma in Females can also involve Neck Lymph nodes. Regional metastasis is more frequent in Level-II, III and distant metastasis is present predominantly in Supraclavicular Lymph nodes.

Contribution by Authors

(1) Dr. Siddharth, Resident Doctor has collected all the samples, examined and interpreted all the smears and slides and corresponded with Journal Editors.

(2) Dr. Dhaval as Senior Consultant and PG Guide, supervised and guided him in all steps and improved at his best.

What this study adds to existing Knowledge: We hope, this study will helpthe pathologists to know the incidence of various metastatic malignancies in cervical nodes&clinicians to know the probable primary site origin in case of metastasis of unknown origin in cervical lymph nodes.

Abbreviations

AOM- Angle of Mouth

BM- Buccal Mucosa

BOT- Base of Tongue

FNAC- Fine Needle Aspiration Cytology

IHC- Immunohistochemistry

LN- Lymph Node

PNET- Primitive Neuroectodermal Tumor

RCC- Renal Cell Carcinoma

SCC- Squamous Cell Carcinoma

References

1. Stanley P. L. Leong, Blake Cady, David M. Jablons, Julio Garcia-Aguilar, Douglas Reintgen, J. Jakub, S. Pendas, L. Duhaime, R. Cassell, M. Gardner, et al. Cancer Metastasis Rev. 2006 Jun; 25(2): 221–232. doi: 10.1007/s10555-006-8502-8.

2. López F, Rodrigo JP, Silver CE, et al. Cervical lymph node metastases from remote primary tumor sites. Head Neck. 2016 Apr;38 Suppl1:E2374-85. doi: 10.1002/hed.24344. Epub 2015 Dec 29.[pubmed]

3. Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations. APMIS. 2003 Dec;111(12):1089-94.[pubmed]

4. Dabbs D. Immunohistology of metastatic carcinoma of unknown primary in Diagnostic Immunohistochemistry. Churchill Livingstone, second edit.2006.

5. Jesse RH, Perez CA, Fletcher GH. Cervical lymph node metastasis: unknown primary cancer. Cancer. 1973 Apr;31(4):854-9.[pubmed]

6. Rai NN, Pratangia P, Meena SP. Role of fine needle aspiration cytology in diagnosis of metastatic lymphadenopathy. J. Evid. Based Med. Healtc. 2016; 3(18), 738-741

7. Buckley JG, Feber T. Surgical treatment of cervical node metastases from squamous carcinoma of the upper aerodigestive tract: evaluation of the evidence for modifications of neck dissection. Head Neck. 2001 Oct;23(10):907-15.[pubmed]

8. Wagh A. Cervical Lymph Nodes: A Hotbed for Metastasis of Malignancy. Clin Oncol. 2018; 3: 1497.

9. Selvasekaran R, Cherian JV, Venkataraman J. Metastasis of hepatocellular carcinoma to Virchow's node: have the tumor cells gone astray? Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):650-2.[pubmed]

10. Bennett AK, Mills SE, Wick MR. Salivary-type neoplasms of the breast and lung. Semin Diagn Pathol. 2003 Nov;20(4):279-304.[pubmed]

11. Minna, JD.; Higgins, GA.; Glatstein, EJ. Cancer of the lung. In: DeVita, VT., Jr; Lawrence, TS.; Rosenberg, SA., editors. DeVita, Hellman, and Rosenberg’s Cancer: principles & practice of oncology. 10. Philadelphia, PA: Wolters Kluwer Health; 1982. p. 396-474.

12. Carlson ER, Reddi SP, Monteleone KL. Metastatic lung cancer of the neck: report of 2 cases. J Oral Maxillofac Surg. 2002 Sep;60(9):1057-61.[pubmed]

13. Davis RS, Flynn MB, Moore C. An unusual presentation of carcinoma of the lung: 26 patients with cervical node metastases. J Surg Oncol. 1977;9(5):503-7.[pubmed]

14. Aldridge T, Kusanale A, Colbert S, Brennan PA. Supraclavicular metastases from distant primaries: what is the role of the head and neck surgeon? Br J Oral Maxillofac Surg. 2013; 51:288–293.[pubmed]

15. El-Foll HA, El-Sebaey HI, El-Kased AF, Hendawy A, Kamel MM (2015) Pattern and Distribution of Lymph Node Metastases in Papillary Thyroid Cancer. J Clin Exp Pathol 5:204.

16. Schuller DE. Management of cervical metastasis in head and neck cancer. Washington, D.C.: American Academy of Otolaryngology, Head and Neck Surgery Foundation; 1982

17. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):751-8.[pubmed]

18. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972 Jun;29(6):1446-9.[pubmed]

19. Alberto Daniele Arosio, Lorenzo Pignataro, Renato Maria Gaini, Werner Garavello, Neck lymph node metastases from unknown primary.Cancer Treat Rev. 2016 Dec 10; 53: 1–9

20. Shukla P, Gupta D, Bisht SS, et al. Metastatic squamous cell carcinoma neck with occult primary: A retrospective analysis. Indian J Med Paediatr Oncol. 2009;30(4):124-30

How to cite this article? 

Jetly D, Thummar S. Pattern of Metastasis in Cervical Lymph Nodes and Topographic Distribution of Primary Site: Study of 375 Cases. Trop J Path Micro 2019;5(3):137-143.doi:10.17511/jopm.2019.i3.05.